Literature DB >> 3033262

Visna virus exhibits a complex transcriptional pattern: one aspect of gene expression shared with the acquired immunodeficiency syndrome retrovirus.

J L Davis, S Molineaux, J E Clements.   

Abstract

A complex pattern of gene expression was found for visna virus in a highly permissive cell culture system in vitro. In addition to the genomic RNA (9.4 kilobases [kb]), five other mRNAs were detected. The three large RNA transcripts (5.0 kb and a doublet at 4.3 kb) arise by a single splicing event joining 5' sequences to sequences located at positions 3' to the pol gene. The two smallest transcripts (1.8 and 1.5 kb) are at least doubly spliced mRNAs which contain sequences derived from the 5' end of the genome, the region between the pol and env genes, and 3' terminal sequences. In addition to this complex pattern of transcription, the mRNAs appear to be regulated temporally. The 1.5-kb mRNA appears 6 h later than the other transcripts. The significance of this complex pattern of gene expression in the unique aspects of the lentivirus life cycle and pathogenesis is considered.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033262      PMCID: PMC254106          DOI: 10.1128/JVI.61.5.1325-1331.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Efficeint transcription of RNA into DNA by avian sarcoma virus polymerase.

Authors:  J M Taylor; R Illmensee; J Summers
Journal:  Biochim Biophys Acta       Date:  1976-09-06

2.  HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA.

Authors:  M B Feinberg; R F Jarrett; A Aldovini; R C Gallo; F Wong-Staal
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

3.  Ovalbumin messenger ribonucleic acid translation. Comparable rates of polypeptide initiation and elongation on ovalbumin and globin messenger ribonucleic acid in a rabbit reticulocyte lysate.

Authors:  R D Palmiter
Journal:  J Biol Chem       Date:  1973-03-25       Impact factor: 5.157

4.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

5.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

6.  Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages.

Authors:  O Narayan; S Kennedy-Stoskopf; D Sheffer; D E Griffin; J E Clements
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

Review 7.  The slow infection caused by visna virus.

Authors:  A T Haase
Journal:  Curr Top Microbiol Immunol       Date:  1975       Impact factor: 4.291

8.  S1 nuclease mapping of viral RNAs from a temperature-sensitive transformation mutant of murine sarcoma virus.

Authors:  M Nash; N V Brown; J L Wong; R B Arlinghaus; E C Murphy
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

9.  Increased concentration of an indigenous proviral mouse mammary tumor virus long terminal repeat-containing transcript is associated with neoplastic transformation of mammary epithelium in C3H/Sm mice.

Authors:  D E Graham; D Medina; G H Smith
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

10.  Genetic variation among lentiviruses: homology between visna virus and caprine arthritis-encephalitis virus is confined to the 5' gag-pol region and a small portion of the env gene.

Authors:  J M Pyper; J E Clements; S M Molineaux; O Narayan
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

View more
  14 in total

1.  Structural and functional analysis of the visna virus Rev-response element.

Authors:  L S Tiley; B R Cullen
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

2.  Replication and cytopathic effects of ovine lentivirus strains in alveolar macrophages correlate with in vivo pathogenicity.

Authors:  M D Lairmore; G Y Akita; H I Russell; J C DeMartini
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  Conserved functional organization of the human immunodeficiency virus type 1 and visna virus Rev proteins.

Authors:  L S Tiley; M H Malim; B R Cullen
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

4.  Analysis of the transcription pattern and mapping of the putative rev and env splice junctions of bovine immunodeficiency-like virus.

Authors:  M S Oberste; J D Greenwood; M A Gonda
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

5.  Analysis of splicing patterns of human spumaretrovirus by polymerase chain reaction reveals complex RNA structures.

Authors:  W Muranyi; R M Flügel
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

6.  Characterization of a cDNA clone encoding the visna virus transactivating protein.

Authors:  J L Davis; J E Clements
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

7.  Genetic structure and function of an early transcript of visna virus.

Authors:  V Mazarin; I Gourdou; G Quérat; N Sauze; R Vigne
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

8.  Lentivirus-induced lymphoproliferative disease. Comparative pathogenicity of phenotypically distinct ovine lentivirus strains.

Authors:  M D Lairmore; J M Poulson; T A Adducci; J C DeMartini
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

9.  Visna virus encodes a post-transcriptional regulator of viral structural gene expression.

Authors:  L S Tiley; P H Brown; S Y Le; J V Maizel; J E Clements; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

10.  Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus.

Authors:  T R Phillips; C Lamont; D A Konings; B L Shacklett; C A Hamson; P A Luciw; J H Elder
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.